Hall WD, M Pettinger, A Oberman et al. Risk factors for kidney stones in older women in the Southern United States. Am J Med Sci 2001; 322:12-18
Hogan DB, FA MacDonald, J Betts et al. A randomized controlled trial of a communnity-based consultation service to prevent falls. CMAJ 2001; 165:537-543
Hsieh C, KD Novielli, JJ Diamond, D Cheruva. Health beliefs and attitudes towrd the prevention of osteoporosis in older women. Menupause 2001; 8:372-376
Juby AG, P Davis. A prospective evaluation of the awareness, knowledge, risk factors and current treatment of ostoporosis in a cohort of elderly subjects. Osteoporosis Int 2001; 12:617-623
Voort DJM, PP Geusens, GJ Dinant. Risk factors for the osteoporosis related to their outcome: Fractures. Osteoporosis Int 2001; 12:630-638
Chrischilles, EA, EJ Dasbach, LM Rubisnstein et al. The effect of alendronate on fracture-related healthcare utilization and costs: The fracture intervention trial. Osteoporosis Int 2001; 12:654-660
Lunt M, P Masaryk, C Scheidt et al. The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: The EVOS Study. Osteoporosis Int 2001; 12:688-698
Damilakis J, K Perisinakis, N Gouurtsoyiannis. Imaging ultrasometry of the calcaneus: optimum T-score thresholds for the identification of osteoporotic subjects. Calcif Tissue Int 2001; 68: 219-224.
Tominaga Y, K Uchida, T Haba et al. More than 1.000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis 2001: 38:168-171.
Berenson AB, CM Radecki, JJ Grady et al. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol 2001; 98:576-582.
Nuti R, G Martini, R Valenti et al. Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern Med 2001; 250: 361316.
Israel E, TR Banerjee, GM Fitzmaurice. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med. 2001; 345:941-947.
Chou FF, JB Chen, CH Lee et al. Parathyroidectomy can improve bone mineral density in patients with symptomatic secondary hyperparathyroidism. Arch Surg 2001; 136:1064-1068.
Schimmer AD, K Mah, L Bordeleau et al. Decreased bone mineral density is common after autologous blood or marrow transplantation. Bone Marrow Transplant. 2001; 28:387-391.
Curry LC, MO Hogstel. Risk status related to knowledge of osteoporosis in older women. J Women Aging. 2001; 13: 71-83.
Seidel C, O Hjertner, N Abildgaard et al. Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease. Blood. 2001; 98:2269-2271.
Griffith K, D Pearson, C Parker et al. The use of a whole body index with bone scintigraphy to mintor the response to theraphy in Paget's disease. Nucl Med Commun. 2001; 22:1069-1075.
Valmadrid C, C Voorhees, B Litt. Practice Patterns of Neurologist Regarding Bone and Mineral Effects of Antiepileptic Drug Therapy. Arch Neurol 2001; 58:1369-1374.
Goemaere S, I Van Pottelberg, H Zmierczak et al. Inverse association between bone turnover rate and bone mineral density in community-dwelling men>70 years of age: no major role of sex steroid status. Bone 2001; 29:286-291.
Bord S, S Beavan, D Ireland. Mechanism by wich high-dose estrogen theraphy produces anabolic skeletal effects in postmenopausal women: role of locally produced growth factors. Bone 2001; 29(3): 216-22.

Fox KM, SR Cummings, E Williams et al. Femoral neck amd intertrochanteric fractures have different risk factors: a prospective study. Osteoporosis Int 2000; 11:1018-1023.
Francis RM, SO Baillie, AJ Chunck et al. Management of osteoporosis in patients with hip fractures. Q J Med 2000; 93:501-506.
Seeman E, Duan Y, Fong C, Edmonds J. Fracture site-specific deficits in bone size and volumetric density in men hip fractu-res. J Bone Miner Res 2001; 16:120-7.
Heidenreich A, Hofmann R, Engelmann UH. The use of bisphospho-nate for the palliative treatment of pain bone metastasis due to hormone refractory prostate cancer. J Urol 2001; 165: 136-40.
Lindsay, R, SL Silvermnan, C Cooper et al. Risk of new verte-bral fracture in the year following a fracture. JAMA 2001; 285:320-323.
Lane JM, Khan SN, O'Connor WJ, et al. Bisphosphonate therapy in fibrous dysplasia. Clin Orthop 2001; 382: 6-12.
Bekker PJ, D Holloway, A Nakanishi et al. The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res 2001; 16:348-360.
Frost ML, GM Blake, I Fogelman. Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis. J Bone Miner Res 2001; 16:406-416.
Martini G, R Valenti, S Giovani et al. Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmeno-pausal women. Bone 2001; 28:115-117.
Heiskanen JT, H Kroger, M Paakkonen et al. Bone mineral metabolism after total gastrectomy. Bone 2001; 28:123-127.
Karlsson MK, H Magnusson, C Karlsson, E Seeman. The duration of exercise as a regulator of bone mass. Bone 2001; 28:128-132.
Phillipov G, CJ Seaborn, PJ Phillips. Reproducibility of DXA: Potential impact on serial measurements and misclassification of osteoporosis. Osteoporosis Int 2001; 12:49-54.
Wilkinson JM, I Stockley, NFA Peel et al. Effect of pamidronate in preventing local bone loss after total hip arthoplasty: a randomized, double-blind, controlled trial. J Bone Miner Res 2001; 16:565-571.
Van Staa TP, HGM Leufkens, C Cooper. Use of inhaled corticoste-roids and risk of fractures. J Bone Miner Res 2001; 16:581-588.
Tellier V, J De Maeseneer, L De Prints et al. Intensive and prolongued health promotion strategy may increase awareness of osteoporosis among postmenopausal women. Osteoporosis Int 2001; 12:131-135.
Cranney A, G Guyatt, N Krolicki et al. A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis. Osteoporosis Int 2001; 12:140-151.
Zivin JR, T Gooley, RA Zager, MJ Ryan. Hypocalcemia: a pervasive metabolic abnormality in the cdritically ill. Am J Kidney Dis 2001; 37:689-698.
Hakkinen A, T Sokka, A Kotaniemi, P Hannonen. A randomized two-year study of the effects of dynamic strenght training on muscle strenght, disease activity, functional capacity and bone mineral density in early rheumathoid arthritis. Artrtis Rheum 2001; 44:515-522.
Cowell CT, C Wüster,ed. Analytic methods in clinical osteology. Useful predictiors of long-term outcomes or a waste of time and money. Hormone Res 2000; 54(Supp 1):1-74.
Gussiye M, P Terradas, D Yeste et al. Low bone mineral density values in adolescents and young adult Turner syndrome patients increase after long-term transdermal estradiol therapy. Hormone Res 2001; 54:131-135.
Reginster JY, C Christiansen, C Roux et al. Intermitent cyclic tiludronate in the treatment of osteoporosis. Osteoporosis Int 2001; 12:169-177.
Johnell O, A Oden, F Caulin, JA Kanis. Acute and long-term increase in fracture risk after hospitalization for vertebral fracture. Osteoporosis Int 2001; 12:07-214.
Huddlestrom JM, KJ Witford. Medical care of elderly patients with hip fractures. Mayo Clin Proc 2001; 76:295-298
Rauch F, E Schoenau. Changes in bone density during childhood and adolescence: an approach based on bone´s biological organiza-tion. J Bone Miner Res 2001; 16:597-604.
Rosier RN. Expanding the role of the orthopedic surgeon in the treatment of osteoporosis. Clin Orthop 2001; 385:57-67.
Astrom AB, CM Puchalski, DP Sulmasy. Religion, spirituality and health care: social, ethical and practical considerations. Am J Med 2001; 110:283-287.
Clarke R, F Leonessa, JN Welch, TC Skaar. Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Reviw 2001; 53:25-72.
LeBlanc ES, J Janowsky, KBS Chan, HD Nelson. Hormone replace-ment therapy and cognition: systematic review and meta-analysis. JAMA 2001; 285:1489-1499.
Altkorn D, T Vokes. Treatment of postmenopausal osteoporosis. JAMA 285:1415-1418.
Fleisch H. Can biphosphonates be given to patients with fractu-res? J Bone Miner Res 2001; 16:437-330.
Alexander C. Idiopatic osteoporosis: an evolutionary dys-adaptation? Ann Rheum Dis 2001; 60:554-558
Lane NE. Rheum Dis Clin North Am 2001; 27:235-253. An update on glucocorticoid-induced osteoporosis.
Cheung AM. J Hepatol 2001 Feb; 34:337-338. Post-liver trans-plan-ta-tion osteoporosis.
Gold DT. The nonskeletal consequences of osteoporotic fractures. Psycholo-gic and social outcomes. Rheum Dis Clin North Am 2001; 27:255-262.
Peichl P, Griesmacherb A, Marteau R et al. Osteoporosis in systemic lupus erythematosus: prevention and treatment.Lupus 2001; 10:227--232.
Lips P, T Doung, A Oleksik et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001; 86: 1212-1221.
Schwartz AV, DE Sellmeyer, KE Ensrud et al. Older women with diabetes have an increased risk of fracture. A prospective study. J Clin Endocrinol Metab 2001; 86:32-38.
Hrlfrich MH, EJA Gerritsen. Formation of non-resorbing osteoclasts from peripheral blood mononuclear cells of patients with malignant juvenile osteopetrosis. Br J Hemat 2001; 112:64.
Nguten TV, JR Center, PN Sambrook, JA Esiman. Risk factors for proximal humerus, forearm, and wrist fractures in elderly men and women. The Dubbo Osteoporosis Epidemiology Study. Am J Epidemiol 2001; 153:587-595.
Schoon EJ, MCA Müller, C Vermeer et al. Low serum and bone vitamin K status in patients with longstanding Crhon´s disease: another pathogenetic factor of osteoporosis in Chron´s disease. Gut 2001; 48:473-477.
Henini PF, U Berlemann, M Kaufma et al. Augmentation of mechanical properties in osteoporotic vertebral bones - a biochemical investigation of vertebroplasty efficacy with diffe-retns bone cements. Eur Spine J 2001; 10:164-171.
Lu Y, HK Genant, J Shepherd et al. Classification of osteoporo-sis based on bone mineral densities. J Bone Miner Res 2001; 16:901-910.
Baron JA, BY Farhmard, E Weiderpass et al. Cigarette smoking, alcohol comsumption and risk of hip fracture in women. Arch In Med 2001; 161:983-988.
Bauer DC, B Ettinger, MC Nevitt et al. Risk for fracture in woman with low serum levels of thyroid-stimulating hormone. Ann Int Med 2001; 134:561-568.
Skripitz R, P Apenberg. Implant fixation enhancement by intermitent treatment with parathyroid hormone. J Bone Joint Surg(Br) 2001; 83-B:437-440.
Cauley JA, DM Black, E Barrett-Connor et al. Effects of hormone replacement therapy on clinical fractures and heigh loss: The Heart and Estrogen/Progestin Replacement Study(HERS). Am J Med 2001; 110:442-450.
Zborowski JV, Talbott EO, Cauley JA. Polycystic ovary syndrome, androgen excess, and the impact on bone.Obstet Gynecol Clin North Am 2001; 28:135-151.
Kasper MJ, Peterson MG, Allegrante JP. The need for comprehen-sive educational osteoporosis prevention programs for young women: results from a second osteoporosis prevention survey. Arthritis Rheum 2001; 45:28-34.
Gillberg P, Johansson AG, Blum WF et al. Growth hormone secretion and sensitivity in men with idiopathic osteoporosis. Calcif Tissue Int 2001; 68:67-73.
Stevens H, G Jacobs JW, Van Rijk PP, De Klerk JM. Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers. Clin Biochem 2001; 34:131-139.
Sen D, Keen RW. Methotrexate osteopathy demonstrated by techne-tium-99m hdp bone scintigraphy. Clin Nucl Med 2001; 26:38-9--91.
Yosipovitch G, Hoon TS, Leok GC. Suggested rationale for preven-tion and treatment of glucocorti-coid-induced bone loss in dermatologic patients. Arch Dermatol 2001; 137:477-481.
Gooren LJ, Lips P, Gijs L.Osteoporosis and androgen-depleting drugs in sex offenders. Lancet 2001; 357:1208-1209.
Lewis SJ, Smith PE. Osteoporosis prevention in myasthenia gravis: a reminder. Acta Neurol Scand 2001; 103:320-322.
Hauge EM, Mosekilde L, Melsen F, Frydenberg M. How many patients are needed? Variation and design considerations in bone histo-morphometry. Bone 2001; 28:556-562.
Pritchett JW. Statin therapy decreases the risk of osteone-crosis in patients receiving steroids.